glp-1 regulatory news The Ministry of Health and Family Welfare announced intensified surveillance on the supply and promotion of weight loss drugs to ensure ethical pharmaceutical practices. Acting through the Drugs Controller General GLP-1 Receptor Agonists | New

What Eli Lilly Alleged Eli Lillys core arguments centered on a few main claims: False advertising : that Mochi Health marketed compounded tirzepatide as personalized when it was allegedly closer to standardized, mass-produced compounding

10.1161/ATVBAHA.120.314515 Arterioscler Thromb Vasc Biol

Makdissi A, Ghanim H, Vora M, et al

[box type=note]The study authors noted that the daily dose of 1.5 g/d of GPLC taken for 28 days resulted in similar improvements anaerobic sprint performance to taking a single dose of 4.5 g prior to exercise

With a molecular weight of approximately 340-400 Da (depending on counterions), the topical tripeptide copper complex readily penetrates the stratum corneum to interact with dermal fibroblasts

doi:10.1016/j.bbadis.2024.167089